Healthcare Value Capital as of June 30, 2018
Portfolio Holdings for Healthcare Value Capital
Healthcare Value Capital holds 11 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gilead Sciences (GILD) | 20.1 | $7.1M | 100k | 70.84 | |
| Tyme Technologies | 18.6 | $6.6M | 2.1M | 3.16 | |
| Noveliontherapeuti.. | 13.7 | $4.8M | 1.3M | 3.68 | |
| GlaxoSmithKline | 11.4 | $4.0M | 100k | 40.31 | |
| Allergan | 9.4 | $3.3M | 20k | 166.70 | |
| Proshares Tr ultsh nasd biot | 8.3 | $2.9M | 150k | 19.47 | |
| D Fluidigm Corp Del (LAB) | 7.6 | $2.7M | 450k | 5.96 | |
| Amarin Corporation (AMRN) | 5.3 | $1.9M | 600k | 3.09 | |
| Viking Therapeutics (VKTX) | 4.0 | $1.4M | 150k | 9.49 | |
| Antares Pharma | 1.5 | $516k | 200k | 2.58 | |
| Apricus Biosciences | 0.1 | $39k | 100k | 0.39 |
